Signet Therapeutics

Biotechnology

Organoid- and AI-driven cancer drug discovery

Signet Therapeutics is a clinical-stage biotech company pioneering the development of first-in-class targeted cancer therapies using organoids and AI.

Haisheng Zhang

Founder and CEO

Favorite Innovator

Accept the things I cannot change. Change the things I can.

Reinhold Niebuhr

info@sky9capital.com

Silicon Valley

200 Kansas St Ste 200, San Francisco
CA 94103

Singapore

350 Orchard Road #11-08, Suite 52, Shaw House
238868

Shanghai

Suite 1807, Tower 1, Raffles City Changning 1133 Changning Road, Changning District
200051